Cargando…
Mesenchymal Stem Cells Reconditioned in Their Own Serum Exhibit Augmented Therapeutic Properties in the Setting of Acute Respiratory Distress Syndrome
Mesenchymal stem cells (MSCs) are a promising form of therapy for acute respiratory distress syndrome (ARDS). The objective of this study was twofold: (a) to characterize cytokine expression in serum from ARDS subjects receiving MSCs and (b) to determine MSC function following “preconditioning” with...
Autores principales: | Xu, Amy L., Rodriguez, Luis A., Walker, Kerfoot P., Mohammadipoor, Arezoo, Kamucheka, Robin M., Cancio, Leopoldo C., Batchinsky, Andriy I., Antebi, Ben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766690/ https://www.ncbi.nlm.nih.gov/pubmed/31219247 http://dx.doi.org/10.1002/sctm.18-0236 |
Ejemplares similares
-
The effect of acute respiratory distress syndrome on bone marrow-derived mesenchymal stem cells
por: Antebi, Ben, et al.
Publicado: (2018) -
Therapeutic potential of products derived from mesenchymal stem/stromal cells in pulmonary disease
por: Mohammadipoor, Arezoo, et al.
Publicado: (2018) -
Preconditioning in an Inflammatory Milieu Augments the Immunotherapeutic Function of Mesenchymal Stromal Cells
por: Rodriguez, Luis A., et al.
Publicado: (2019) -
Short-term physiological hypoxia potentiates the therapeutic function of mesenchymal stem cells
por: Antebi, Ben, et al.
Publicado: (2018) -
Cryopreserved mesenchymal stem cells regain functional potency following a 24-h acclimation period
por: Antebi, Ben, et al.
Publicado: (2019)